Skip to content

The effect of laser in the treatment of acne

Comparison efficacy of IPL (Intense pulsed light) combined with oral azithromycin with oral azithromycin alone in the treatment of modrate to sever papulopustular Acne vulgaris.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201701099844N4
Enrollment
40
Registered
2017-06-20
Start date
2016-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris. Acne vulgaris

Interventions

Intervention 1: They will Treat with azithromycin 250 mg orally per day and IPL. IPL will perform weekly for 5 weeks for patients in the intervention group. Treatment period is 3 months. Intervention
Treatment - Other
Treatment - Drugs
They will Treat with azithromycin 250 mg orally per day and IPL. IPL will perform weekly for 5 weeks for patients in the intervention group. Treatment period is 3 months.
Control group: Only receive azithromycin 250 mg orally per day. Treatment period is 3 months.

Sponsors

Vice chanscellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with moderate to severe acne; Age ranges between 18 to 40 years. Exclusion criteria: A history of connective tissue disease; Pregnancy and lactation (breast-feeding); a previous history of keloids and hypertrophic scars; Photosensitivity; History of Isotretinoin consumption during the past 6 months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of acne. Timepoint: week zero and third month. Method of measurement: Counting.

Secondary

MeasureTime frame
Number of papule and Pustule. Timepoint: week zero and third month. Method of measurement: Counting.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Amirnia

Tabriz Medical University

amirniam@tbzmed.ac.ir+98 41 3540 6612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026